[Investigation of antihypoxic properties of short peptides].
Kozina. L S LS
Key Findings
- Short regulatory peptides (including vesugen) showed antihypoxic effects in a low‑oxygen animal model
- Pinealon had the strongest protective effect among the tested peptides
- The protective mechanism involves stimulating internal antioxidant enzymes rather than only reducing ROS
Practical Outcomes
- Vesugen may offer some benefit for improving tolerance to low‑oxygen stress, but the evidence is early and lacks dosage or protocol details. Biohackers should view it as a low‑priority supplement pending further research, and not rely on it as a proven performance enhancer.
Summary
The study found that short peptides like vesugen can help protect the body against low‑oxygen conditions, but the effect is modest compared to a peptide called pinealon. The protection seems to come from boosting the body's own antioxidant enzymes rather than just blocking harmful molecules.
Abstract
The data presented suggest that short regulatory peptides (vilon, epitalon, vesugen and pinealon) have manifested the antihypoxic properties in the model of hypobaric hypoxia. Pinealon (Glu-Asp-Arg) has the most pronounced effect among them. The capability of pinealon to increase the neuronal resistance to hypoxic stress in experiments with prenatal hypoxia has a complex nature. It is based not so much on the inhibition of ROS increase in cells in response to stress as on stimulation of internal antioxidative enzyme system and possibly limiting the excitotoxic effect of N-methyl-D-aspartate.
Study Information
pubmed
2008